Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2020

May 15, 2020

SELL
$13.06 - $21.24 $152,802 - $248,507
-11,700 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$17.29 - $21.74 $202,293 - $254,357
11,700 New
11,700 $239,000
Q4 2018

Feb 14, 2019

SELL
$27.94 - $44.61 $181,610 - $289,965
-6,500 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$38.6 - $46.12 $131,240 - $156,808
-3,400 Reduced 34.34%
6,500 $276,000
Q2 2018

Aug 14, 2018

BUY
$40.56 - $51.36 $401,544 - $508,464
9,900 New
9,900 $407,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.8B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.